Cite
Aptamer-Based Immune Drug Systems (AptIDCs) Potentiating Cancer Immunotherapy.
MLA
Xiong, Hongjie, et al. “Aptamer-Based Immune Drug Systems (AptIDCs) Potentiating Cancer Immunotherapy.” Chemistry (2624-8549), vol. 5, no. 3, Sept. 2023, pp. 1656–80. EBSCOhost, https://doi.org/10.3390/chemistry5030114.
APA
Xiong, H., Liu, L., Liu, X., Jiang, H., & Wang, X. (2023). Aptamer-Based Immune Drug Systems (AptIDCs) Potentiating Cancer Immunotherapy. Chemistry (2624-8549), 5(3), 1656–1680. https://doi.org/10.3390/chemistry5030114
Chicago
Xiong, Hongjie, Liu Liu, Xiaohui Liu, Hui Jiang, and Xuemei Wang. 2023. “Aptamer-Based Immune Drug Systems (AptIDCs) Potentiating Cancer Immunotherapy.” Chemistry (2624-8549) 5 (3): 1656–80. doi:10.3390/chemistry5030114.